FDA panel meeting to consider Pfizer's COVID-19 vaccine for young kids
An FDA advisory panel is meeting today to consider if millions of younger children, ages 5 to 11, should be eligible for Pfizer's COVID-19 vaccine. CBS News' Laura Podesta joins CBSN AM with the latest.